Please login to the form below

Not currently logged in
Email:
Password:

UK Prix Galien opens for entries

Pharma R&D accolades will include a new real world evidence category

Prix Galien 2014 winner Novartis 
Pictured: Novartis pick up the 2014 Innovative Product award

Entries have opened for the 2016 UK Prix Galien Awards, which commend pharmaceutical research and development and celebrate outstanding efforts to improve the human condition through the development of novel, high-value medicines.

Established in 1970, the next outing for the bi-annual prizes will include a new real world evidence category, alongside their well-established accolades for innovative products and orphan product.

The 2014 UK Prix Galien was won by Bexserothe first ever vaccine to treat invasive meningococcal disease, and Sirturo, the first TB medication to be approved in four decades.

The Prix Galien is recognised in 17 countries across Europe and North America, with presences in emerging markets in Asia and Latin America expected soon. The UK Prix Galien franchise is now owned by ValueBase, whose experienced team has a long-standing affiliation with the awards. The 2016 UK judging panel is once again led by Professor Sir Michael Rawlins, chair of the MHRA and founding chair of NICE from 1999 to 2014.

Previous UK Prix Galien winners include well-known brands such as Viagra, Herceptin, Glivec, Xolair, Cervarix and Gardasil. More recent winners, such as Xarelto, Incivo and Victrelis, show how pharmaceutical innovation is helping to transform healthcare services and improve public health.

Registration for entries for the 2016 Awards will close on 29 February 2016, with final submissions due by 29 April 2016, as part of a process that culminates in a ceremony at the House of Commons in September 2016.

For further details on the awards and the entry process visit www.prixgalien.co.uk 

Article by
Dominic Tyer

8th December 2015

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Complete Medical Communications (CMC)

CMC is a leading global agency dedicated to healthcare communications across the lifecycle. We combine scientific acumen, excellence in delivery...

Latest intelligence

Marketing to healthcare professionals – what’s the key ingredient missing from most campaigns?
What do you think is the difference between a campaign developed to win a share-of-mind with consumers and a campaign designed to gain the attention of healthcare professionals?...
What everyone forgets about good organisational change in pharma
Natasha Cowan speaks to Daphne Chung, Head of Organisational Transformation, to learn how she ensures smooth organisational change that takes all stakeholders into account....
Live from Singapore: Oncology in APAC - Evaluating the opportunity for novel therapies
Live webinar: Tuesday 11th December 2018,16:00 SGT / 17:00 JST...

Infographics